Norovirus / GI Illness Outbreak Reported Aboard Seven Seas Voyager – January 2026

On 29 January 2026, a limited gastrointestinal illness outbreak was reported aboard Seven Seas Voyager, operated by Regent Seven Seas Cruises (RSSC), during a 14-day roundtrip voyage from Cape Town, South Africa. A small number of guests experienced symptoms consistent with norovirus and stomach flu, prompting the ship to activate established health and sanitation protocols.

The cruise line confirmed that the situation remained under control and did not significantly impact ship operations. Seven Seas Voyager continued its itinerary under heightened health precautions.

RSSC confirmed that a minor proportion of guests reported gastrointestinal symptoms, including vomiting and other stomach-flu-like signs. The cruise line did not disclose a specific case count. Upon identification of the cases, the ship's Sanitation Officer implemented response measures aligned with CDC-approved guidance. Affected guests received medical attention onboard, and isolation protocols were used where appropriate to limit transmission.

Enhanced cleaning and disinfection were applied across cabins, public spaces, and high-touch surfaces throughout the vessel. The ship's medical team provided care to affected guests, and isolation protocols were implemented to prevent further transmission. All measures followed CDC-approved guidance and standard cruise industry practice for gastrointestinal illness management.

Fatalities

• None reported.

Injuries

• None reported.

Rescued

• Not applicable; all guests and crew remained onboard under medical observation and isolation protocols.

Seven Seas Voyager continued its 14-day itinerary under heightened health precautions. The outbreak remained contained and did not disrupt scheduled operations or port calls.